Borrelia Bavariensis VlsE1

Borrelia Bavariensis VlsE1 Recombinant
Cat. No.
BT28617
Source
Escherichia Coli.
Synonyms
Appearance
Sterile Filtered clear solution.
Purity
Greater than 80.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Borrelia Bavariensis VlsE1 ( variable major protein like sequence E1 ) produced in E.coli is a non-glycosylated, polypeptide chain having a calculated molecular mass of 28kDa.

Borrelia Bavariensis VlsE1 is expressed with a -6x His tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
Borrelia, a genus of bacteria belonging to the spirochete phylum, is responsible for causing borreliosis. This zoonotic disease is primarily transmitted through ticks and, in some instances, lice, depending on the specific species. Among the 36 recognized species of Borrelia, 12 are known to cause Lyme disease or borreliosis and are spread by ticks. Notably, Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii are the primary culprits behind Lyme disease. These bacteria possess a linear chromosome of approximately 900 kbp in length, along with an abundance of both linear and circular plasmids ranging in size from 5 to 220 kbp. Unlike conventional bacterial plasmids, these plasmids exhibit unique characteristics, including the presence of numerous paralogous sequences, a substantial number of pseudogenes, and, in certain cases, essential genes. Furthermore, certain plasmids display features suggestive of their nature as prophages.
Description
Recombinant Borrelia Bavariensis VlsE1, also known as variable major protein-like sequence E1, is produced in E. coli. This non-glycosylated polypeptide chain has an estimated molecular mass of 28kDa. Notably, it is expressed with a 6x His tag at the N-terminus and undergoes purification using proprietary chromatographic methods.
Physical Appearance
A clear solution that has undergone sterile filtration.
Formulation
Borrelia Bavariensis VlsE1 is provided in a buffer solution containing 20mM HEPES (pH 7.6), 250mM NaCl, and 20% glycerol.
Stability
For optimal storage, keep the vial at 4°C if it will be completely used within 2-4 weeks. For extended storage, freeze at -20°C. It's important to minimize repeated freeze-thaw cycles.
Purity
SDS-PAGE analysis has determined a purity exceeding 80%.
Applications
One of its primary applications is in Western blotting using patient samples.
Immunological Functions
This protein exhibits two key immunological functions: (1) It demonstrates the ability to bind to both IgG and IgM type human antibodies. (2) It can be utilized in immunodot tests for the analysis of positive and negative samples.
Source
Escherichia Coli.

Product Science Overview

Introduction to Borrelia Bavariensis

Borrelia Bavariensis is a species within the Borrelia genus, which belongs to the spirochete phylum. This genus is known for causing borreliosis, a zoonotic, vector-borne disease primarily transmitted by ticks and, in some cases, by lice. Among the 36 known species of Borrelia, 12 are recognized for causing Lyme disease or borreliosis. The primary species responsible for Lyme disease include Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii .

Genetic Characteristics

Members of the Borrelia genus possess a linear chromosome approximately 900 kilobase pairs (kbp) in length. Additionally, they have an array of both linear and circular plasmids ranging from 5 to 220 kbp. These plasmids are atypical compared to most bacterial plasmids, as they contain numerous paralogous sequences, a significant number of pseudogenes, and, in some cases, essential genes. Some plasmids also exhibit features suggesting they are prophages .

VlsE1 Protein

The VlsE1 (Variable major protein-like sequence E1) is a key protein in Borrelia species. It plays a crucial role in the immune evasion mechanisms of the bacteria. The VlsE1 protein undergoes antigenic variation, allowing the bacteria to evade the host’s immune response. This variation is achieved through recombination events within the vlsE gene, leading to the expression of different VlsE1 variants on the bacterial surface .

Recombinant VlsE1

Recombinant Borrelia Bavariensis VlsE1 is produced in Escherichia coli (E. coli) and is a non-glycosylated polypeptide chain with a calculated molecular mass of 28 kDa. It is expressed with a 6x His tag at the N-terminus and purified using proprietary chromatographic techniques. The recombinant VlsE1 is supplied in a sterile filtered clear solution and formulated in 20mM HEPES buffer (pH 7.6), 250mM NaCl, and 20% glycerol .

Applications and Stability

Recombinant VlsE1 is used in various immunological assays, including Western blotting with patient samples and immunodot tests with positive and negative samples. It binds to IgG- and IgM-type human antibodies, making it a valuable tool for serodiagnosis of Lyme borreliosis. The protein is stable when stored at 4°C for short-term use (2-4 weeks) and at -20°C for long-term storage. It is important to avoid multiple freeze-thaw cycles to maintain its stability .

Diagnostic Performance

The ZEUS Borrelia VlsE1/pepC10 assay, which utilizes recombinant VlsE1, has shown comparable diagnostic parameters to the C6-ELISA, a commonly used assay for Lyme borreliosis. The VlsE1/pepC10 assay has demonstrated potentially improved specificity in sera with cross-reactive antibodies, making it a useful tool for the serodiagnosis of Lyme borreliosis in Europe .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.